BioNTech: ‘No evidence’ COVID vaccine needs adapting for variants

German company says the shot it developed with US pharmaceutical giant Pfizer does not require modifications for now.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…